Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) Fundamentals

Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
SHARE INFORMATION
Market Cap$ 23,014,922
Shares Outstanding27,191,543
Float27,191,543
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 853,000
Latest Fiscal EPS$ -0.90
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions15
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months65,720
Institutional Holdings Percent1.4%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 2.60
52 Week Low$ 0.78
52 Week High Change$ -59.11
21 Day Moving Average$ 0.8498
21 Day Extended Moving Average$ 0.851226
50 Day Moving Average$ 0.8825
50 Day Extended Moving Average$ 0.883857
200 Day Moving Average$ 1.1049
200 Day Extended Moving Average$ 1.1443
10 Day Average Volume71,981
20 Day Average Volume160,673
30 Day Average Volume724,911
50 Day Average Volume466,194
Alpha-0.052116
Beta1.6248
Standard Deviation0.192541
R20.178142
7 Day Price Change$ 0.0166
7 Day Percent Change2.0%
21 Day Price Change$ 0.0454
21 Day Percent Change5.67%
30 Day Price Change$ -0.0536
30 Day Percent Change-5.96%
Month to Date Price Change$ 0.0162
Month to Date Percent Change1.95%
Quarter to Date Price Change$ -0.0736
Quarter to Date Percent Change-8.0%
180 Day Price Change$ -0.2836
180 Day Percent Change-25.1%
200 Day Price Change$ -0.4636
200 Day Percent Change-35.39%
Year to Date Price Change$ -0.4436
Year to Date Percent Change-34.39%

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) Key Ratios

PROFITABILITY
EBIT Margin-1,433.1%
EBITDA Margin-1,433.1%
Pre-Tax Profit Margin-1,115.8%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 660,000
Revenue Per Share$ 0.0243
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.90
Total Debt To Equity0.00
Int Coverage-97.80
Current Ratio6.10
Leverage Ratio1.40
Quick Ratio5.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.00
Enterprise Value$ 7,675,701
Price to Sales34.8711
Price to Free Cash-2.30
PE High Last 5 Years-1.20
Price To Book1.90
Price To Cash Flow0.00
PE Low Last 5 Years-2.60
Price to Tangible Book1.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover81.40
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-105.50
Return on Equity-168.50
Return on Capital-163.61

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) Profile

PROFILE INFO
Issue TypeCS
SEC TypeDR
AuditorKost Forer Gabbay & Kasierer
CEOPnina Fishman
Emplyoees8
Last AuditUQ
CIK0001536196
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Address10 Bareket Street, Kiryat Matalon
P.O. Box 7537
Petah-Tikva, 4951778
Websitehttp://www.canfite.com
Facsimile+972 39249378
Telephone+972 39241114
Email-


Your Recent History
AMEX
CANF
Can Fite B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.